Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Roboclinic vs TeleHealth Med

Roboclinic
Graded #223

Lower grade

vs+0.7999999999999972
TeleHealth Med
Graded #209

Higher grade

The verdict

TeleHealth Med takes it — 66.1/100 to 65.3/100, but only just.

TeleHealth Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed… Roboclinic is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +23
51
74
Dose & formulationRoboclinic +12
75
63
Clinical oversightRoboclinic +8
84
76
Labs & monitoringRoboclinic +1
53
52
FulfillmentRoboclinic +12
75
63
Contract termsTeleHealth Med +8
47
55
Roboclinic · left barTeleHealth Med · right bar

The numbers

MetricRoboclinicTeleHealth Med
WeighScore65.3/10066.1/100
GradeCC
Scorecard rank#223#209
Semaglutide$179/mo (12-month plan, compounded)$147/mo (starting dose, compounded)
Tirzepatide$299/mo (12-month plan, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Roboclinic

Graded #223 · C

Strengths

  • Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
  • One all-in price bundles the provider consult, prescription, and delivery
  • Offers both injectable and oral (tablet) compounded semaglutide
  • 'Same price, every dose' means your cost does not rise as the dose increases
  • AI-first intake with board-certified provider review; no insurance necessary

Where it loses points

  • Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
  • Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
  • No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
  • Refunds limited to your most recent billing cycle; none for used or partially used periods
  • Operated by BrickFi, Inc., a newer brand with limited independent track record
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard